Tissue-Advanced Glycation End Product Concentration in Dialysis Patients | Zendy

Natasha J. McIntyre | Zendy; Lindsay Chesterton | Zendy; Stephen G. John | Zendy; Helen J. Jefferies | Zendy; James O. Burton | Zendy; Maarten W. Taal | Zendy; Richard Fluck | Zendy; Christopher W. McIntyre | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Tissue-Advanced Glycation End Product Concentration in Dialysis Patients

Author(s) -

Natasha J. McIntyre,

Lindsay Chesterton,

Stephen G. John,

Helen J. Jefferies,

James O. Burton,

Maarten W. Taal,

Richard Fluck,

Christopher W. McIntyre

Publication year - 2009

Publication title -

clinical journal of the american society of nephrology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.755

H-Index - 151

eISSN - 1555-905X

pISSN - 1555-9041

DOI - 10.2215/cjn.05350709

Subject(s) - medicine , dialysis , diabetes mellitus , hemodialysis , glycation , advanced glycation end product , kidney disease , peritoneal dialysis , endocrinology , gastroenterology

Tissue-advanced glycation end products (AGE) are a measure of cumulative metabolic stress. Assessment of tissue AGE by skin autofluoresence (AF) correlates well with cardiovascular outcomes in hemodialysis (HD) patients. This study aimed to measure and compare tissue AGE levels in HD and peritoneal dialysis (PD) patients and to evaluate the impact of systemic PD glucose exposure.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research